Download Citation
Article Source:
ZNF503-AS2 is a promising therapeutic target and is associated with the immune microenvironment in glioma
Wu Y,
Mu G,
Li F,
Sun Y,
Lin X,
et al.
(2024)
ZNF503-AS2 is a promising therapeutic target and is associated with the immune microenvironment in glioma.
PLOS ONE 19(12): e0314618.
https://doi.org/10.1371/journal.pone.0314618